IN8BIO, INC. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
IN8bio established a 2026 Inducement Plan effective July 31, 2026, authorizing 500,000 shares of common stock for equity awards (options, RSUs, SARs, restricted stock, performance awards) to eligible new employees as inducement to employment under Nasdaq Rule 5635(c)(4). No specific grants or dollar amounts disclosed in this filing; the document sets forth plan mechanics, vesting, exercise procedures, tax withholding, and change-of-control provisions. Awards must be approved by independent directors or independent compensation committee.
Why this rating
Routine plan adoption. 500k shares at ~$7.6M market cap = ~6.6% dilution reserve; material but standard. No grants yet announced; no counterparties, amounts, or timing specified.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.